Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01202630Phase 3Suspended
BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection
Recurrent Clostridium Difficile Infection
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Parker Jewish for Health Care and Rehabilitation

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dimitri Drekonja, MD

Veteran Administration Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Christine Lee, MD

Vancouver Island Health Authority

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Ebbing Lautenbach, MD, MPH, MSCE

University of Pennsylvania

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Zain Kassam, MD, MPH

Finch Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Susy Hota, MD FRCPC

Infectious Disease, Infection Prevention and Control, Epidemiologist

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Dina Kao, MD

University of Alberta

Moderately Similar
8 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Susan Poutanen, MD MPH FRCPC

Infectious Disease, Microbiologist

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Alexander Khoruts, MD

University of Minnesota

Moderately Similar
4 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Javier Cobo, MD

Hospital Universitario Ramon y Cajal

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Nasia Safdar, MD PhD

University of Wisconsin, Madison

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent Clostridium Difficile Infection
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01202630Phase 3PrincipalInvestigator

BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

Recurrent Clostridium Difficile Infection
Suspended

All 1 trials loaded